Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)

The summary for the Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed): This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is already present (for example, in a model of AD/ADRD). - Mechanistic studies that address how COVID-19 accelerates AD/ADRD pathology and cognitive deficits in a prodromal model (early phase, pre-symptomatic). - Mechanistic studies that address how COVID-19 predisposes for AD/ADRD and/or interacts with relevant comorbid conditions and risk factors (cellular mechanisms that could potentially increase the risk for future AD/ADRD).
Federal Grant Title: Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-24-203
Type of Funding: Grant
CFDA Numbers: 93.853, 93.866
CFDA Descriptions: Information not provided
Current Application Deadline: October 4th, 2024
Original Application Deadline: October 4th, 2024
Posted Date: April 12th, 2024
Creation Date: April 12th, 2024
Archive Date: November 9th, 2024
Total Program Funding:
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: April 12th, 2024
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-24-203.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Ge...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contribution...
Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging fin...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Opti...
Access and Manipulation of Brain Cell Subtypes Implicated in Aging and AD/ADRD (R61/R33 Cl...
Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
Nutrition Obesity Research Centers Research Resource Center (RRC) (P2C- Clinical Trial Opt...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com